Sign in
4

Changes in Ownership

PTC THERAPEUTICS, INC. Filed Acc 0001179110-20-010348

Chief Executive Officer sold 179,811 shares at an average $50.09 ($9,006,083)

  • Chief Executive Officer acquired 179,811 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Peltz Stuart Walter · Chief Executive Officer

Table I: Non-derivative

10 lines
Date Transaction Shares Price Value Owned after D/I
2020-10-05 Exercise or conversion : show line 1 in the form +900 $10.85 $9,765 56,985 D
2020-10-05 Sale : show line 2 in the form −900 $50.00 $45,000 56,085 D
2020-10-05 Exercise or conversion : show line 3 in the form +54,560 $10.85 $591,976 110,645 D
2020-10-05 Sale : show line 4 in the form −54,560 $50.00 $2,728,000 56,085 D
2020-10-06 Exercise or conversion : show line 5 in the form +50,015 $10.85 $542,663 106,100 D
2020-10-06 Sale : show line 6 in the form −50,015 $50.10 $2,505,852 56,085 D
2020-10-06 Exercise or conversion : show line 7 in the form +22,511 $10.85 $244,244 78,596 D
2020-10-06 Sale : show line 8 in the form −22,511 $50.15 $1,128,882 56,085 D
2020-10-06 Exercise or conversion : show line 9 in the form +51,825 $11.23 $581,995 107,910 D
2020-10-06 Sale : show line 10 in the form −51,825 $50.14 $2,598,350 56,085 D
Open-market sales · 179,811 sh · avg $50.09 · $9,006,083

Table II: Derivative

5 lines
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2020-10-05 Exercise or conversion : show line 11 in the form Stock Option (Right To Buy) −900 $10.85 $9,765 $10.85 2023-05-15 900 102,130 D
2020-10-05 Exercise or conversion : show line 12 in the form Stock Option (Right To Buy) −54,560 $10.85 $591,976 $10.85 2023-05-15 54,560 56,134 D
2020-10-06 Exercise or conversion : show line 13 in the form Stock Option (Right to Buy) −50,015 $10.85 $542,663 $10.85 2023-05-15 50,015 52,115 D
2020-10-06 Exercise or conversion : show line 14 in the form Stock Option (Right to Buy) −22,511 $10.85 $244,244 $10.85 2023-05-15 22,511 33,623 D
2020-10-06 Exercise or conversion : show line 15 in the form Stock Option (Right To Buy) −51,825 $11.23 $581,995 $11.23 2027-01-02 51,825 74,175 D
Loading xslF345X03/edgar.xml…